1-50 of 71
Keywords: Alzheimer's disease
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2025) 482 (12): 877–899.
Published: 17 June 2025
.... The most studied PTMs of tau are phosphorylation and acetylation; however, the salience of other PTMs is not fully explored. Tissue transglutaminase (TG) is an enzyme whose activity is elevated in Alzheimer’s disease (AD). TG action on tau may lead to intramolecular and intermolecular cross-linking along...
Includes: Supplementary data
Articles
Biochem J (2021) 478 (17): 3297–3317.
Published: 14 September 2021
...Piyali Majumder; Kaushik Chanda; Debajyoti Das; Brijesh Kumar Singh; Partha Chakrabarti; Nihar Ranjan Jana; Debashis Mukhopadhyay Alzheimer's Disease (AD) and Type 2 Diabetes (T2D) share a common hallmark of insulin resistance. Reportedly, two non-canonical Receptor Tyrosine Kinases (RTKs), ALK...
Includes: Supplementary data
Articles
Biochem J (2021) 478 (2): 327–339.
Published: 22 January 2021
... were enabled. Correspondence: Michael G. Friedrich ([email protected]) 18 10 2020 15 12 2020 18 12 2020 21 12 2020 © 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2021 age Alzheimer's disease human lens...
Includes: Supplementary data
Articles
Biochem J (2020) 477 (23): 4581–4597.
Published: 08 December 2020
...Min Kyoung Kam; Dong Gil Lee; Bokyung Kim; Jae-Won Huh; Hong Jun Lee; Young-Ho Park; Dong-Seok Lee Alzheimer's disease (AD) is a neurodegenerative disease associated with the accumulation of amyloid-beta oligomers (AβO). Recent studies have demonstrated that mitochondria-specific autophagy...
Includes: Supplementary data
Articles
Articles
Articles
Biochem J (2019) 476 (5): 859–873.
Published: 12 March 2019
...) and Alzheimer's disease (AD). Their precise mechanism in these pathologies remains uncertain, but both inflammatory and lysosomal roles have been observed for GRNs. Among the seven GRNs, GRN-3 is well characterized and is implicated within the context of FTD. However, the relationship between GRN-3 and amyloid-β...
Includes: Supplementary data
Articles
Biochem J (2018) 475 (19): 3087–3103.
Published: 10 October 2018
...Ofek Oren; Victor Banerjee; Ran Taube; Niv Papo Aggregation and accumulation of the 42-residue amyloid β peptide (Aβ42) in the extracellular matrix and within neuronal cells is considered a major cause of neuronal cell cytotoxicity and death in Alzheimer's disease (AD) patients. Therefore...
Includes: Supplementary data
Articles
Articles
Biochem J (2017) 474 (11): 1853–1866.
Published: 16 May 2017
... ) 1 12 2016 11 4 2017 13 4 2017 13 4 2017 © 2017 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society 2017 Alzheimer's disease calcium signaling co-chaperone NMR spectroscopy tetratricopeptide repeat The S100 family...
Includes: Supplementary data
Articles
Biochem J (2017) 474 (3): 333–355.
Published: 20 January 2017
... in neurological diseases, including Alzheimer's disease (AD). These changes may reflect a change from a neuroprotective to a neurotoxic phenotype. Given the lack of current disease-modifying therapies for AD, astrocytes have become an interesting and viable target for therapeutic intervention. The astrocyte...
Articles
Biochem J (2016) 473 (20): 3683–3704.
Published: 11 October 2016
... in Alzheimer's disease (AD), for which no effective treatment exists. The BRICHOS domain is a part of several disease-related proproteins, the most studied ones being Bri2 associated with familial dementia and prosurfactant protein C (proSP-C) associated with lung amyloid. BRICHOS from proSP-C has been found...
Includes: Supplementary data
Articles
Biochem J (2016) 473 (16): 2429–2437.
Published: 11 August 2016
...Dirk Mielenz; Frank Gunn-Moore Synaptic dysfunction and dysregulation of Ca 2+ are linked to neurodegenerative processes and behavioural disorders. Our understanding of the causes and factors involved in behavioural disorders and neurodegeneration, especially Alzheimer's disease (AD), a tau-related...
Articles
Biochem J (2016) 473 (14): 2119–2130.
Published: 12 July 2016
...Andrzej Maciejewski; Valeriy G. Ostapchenko; Flavio H. Beraldo; Vania F. Prado; Marco A.M. Prado; Wing-Yiu Choy Soluble oligomers of amyloid-beta peptide (AβO) transmit neurotoxic signals through the cellular prion protein (PrP C ) in Alzheimer's disease (AD). Secreted stress-inducible...
Articles
Biochem J (2016) 473 (2): 167–178.
Published: 05 January 2016
...Lisa Dolfe; Bengt Winblad; Jan Johansson; Jenny Presto The BRICHOS domain is associated with proliferative, degenerative and amyloid diseases, and it has been shown to inhibit fibril formation and toxicity of the Alzheimer's disease-associated amyloid β-peptide. ProSP-C (prosurfactant protein C...
Includes: Supplementary data
Articles
Biochem J (2016) 473 (1): 21–30.
Published: 09 December 2015
...Yasuhiko Kizuka; Miyako Nakano; Shinobu Kitazume; Takashi Saito; Takaomi C. Saido; Naoyuki Taniguchi β-Site amyloid precursor protein-cleaving enzyme-1 (BACE1) is a protease essential for amyloid-β (Aβ) production in Alzheimer's disease (AD). BACE1 protein is known to be up-regulated by oxidative...
Includes: Supplementary data
Articles
Articles
Biochem J (2015) 466 (2): 233–242.
Published: 20 February 2015
...Christian J. Matheou; Nadine D. Younan; John H. Viles Central to Alzheimer's disease is the misfolding of amyloid-beta (Aβ) peptide, which generates an assorted population of amorphous aggregates, oligomers and fibres. Metal ion homoeostasis is disrupted in the brains of sufferers of Alzheimer's...
Articles
Biochem J (2015) 465 (3): 413–421.
Published: 22 January 2015
... of Alzheimer's disease (AD) and AICD has important roles in the regulation of gene transcription (in complex with Fe65). It is therefore important to understand how Fe65 is regulated and how this contributes to the function and/or processing of APP. Studies have also implicated Fe65 in the cellular DNA damage...
Articles
Biochem J (2014) 464 (1): 85–98.
Published: 23 October 2014
...Katelyn M. Seither; Heather A. McMahon; Nikita Singh; Hejia Wang; Mimi Cushman-Nick; Geronda L. Montalvo; William F. DeGrado; James Shorter Amyloid fibrils are self-propagating entities that spread pathology in several devastating disorders including Alzheimer's disease (AD). In AD, amyloid-β (Aβ...
Articles
Articles
Articles
Biochem J (2014) 461 (3): 413–426.
Published: 10 July 2014
...Tiernan T. O’Malley; Nur Alia Oktaviani; Dainan Zhang; Aleksey Lomakin; Brian O’Nuallain; Sara Linse; George B. Benedek; Michael J. Rowan; Frans A. A. Mulder; Dominic M. Walsh Dimers of Aβ (amyloid β-protein) are believed to play an important role in Alzheimer's disease. In the absence...
Includes: Supplementary data
Articles
Articles
Biochem J (2013) 450 (2): 265–274.
Published: 15 February 2013
... The Authors Journal compilation © 2013 Biochemical Society 2013 Alzheimer’s disease heart failure Parkinson’s disease sepsis synaptic vesicle vascular dementia Cholinergic neurons in the CNS (central nervous system) and in the periphery secrete the neurotransmitter ACh (acetylcholine...
Includes: Multimedia, Supplementary data
Articles
Articles
Biochem J (2012) 446 (2): 165–177.
Published: 14 August 2012
...Andrew F. Teich; Ottavio Arancio The conventional view of AD (Alzheimer's disease) is that much of the pathology is driven by an increased load of β-amyloid in the brain of AD patients (the ‘Amyloid Hypothesis’). Yet, many therapeutic strategies based on lowering β-amyloid have so far failed...
Articles
Biochem J (2012) 443 (1): 57–64.
Published: 14 March 2012
...Amy R. Cameron; Katherine Wallace; Lisa Logie; Alan R. Prescott; Terry G. Unterman; Jean Harthill; Graham Rena Many diseases of aging including AD (Alzheimer's disease) and T2D (Type 2 diabetes) are strongly associated with common risk factors, suggesting that there may be shared aging mechanisms...
Articles
Articles
Articles
Biochem J (2012) 441 (1): 39–59.
Published: 14 December 2011
... invasion and amyloid production in Alzheimer's disease. 1 To whom correspondence should be addressed (email [email protected] ). 11 7 2011 26 7 2011 27 7 2011 © The Authors Journal compilation © 2012 Biochemical Society 2012 Alzheimer's disease endosome...
Includes: Multimedia, Supplementary data
Articles
Biochem J (2011) 439 (1): 67–77.
Published: 14 September 2011
...Thomas L. Williams; Benjamin R. G. Johnson; Brigita Urbanc; A. Toby A. Jenkins; Simon D. A. Connell; Louise C. Serpell Aβ (amyloid-β peptide) assembles to form amyloid fibres that accumulate in senile plaques associated with AD (Alzheimer's disease). The major constituent, a 42-residue Aβ, has...
Includes: Supplementary data
Articles
Biochem J (2011) 438 (3): 415–426.
Published: 26 August 2011
... of fibril growth during disease progression has been revealed by AFM ( Figure 5 ). 1 email [email protected] 28 2 2011 28 4 2011 4 5 2011 26 8 2011 © The Authors Journal compilation © 2011 Biochemical Society 2011 Alzheimer's disease computer simulation...
Includes: Multimedia, Supplementary data
Articles
Biochem J (2011) 438 (1): 165–175.
Published: 27 July 2011
...) analysis of sphingolipids based on both mass and hydrophobicity, and use this method to characterize the SM (sphingomyelin), ceramide and GalCer (galactosylceramide) content of hippocampus from AD (Alzheimer's disease) and control subjects. Using a mathematical relationship we exclude the influence...
Includes: Supplementary data
Articles
Biochem J (2011) 437 (3): 469–475.
Published: 13 July 2011
... to generate a plasma-membrane Ca 2+ conductance and has been proposed to influence Alzheimer's disease risk. In the present study we have investigated the effects of CALHM1 on intracellular Ca 2+ handling in HEK-293T [HEK (human embryonic kidney)-293 cells expressing the large T-antigen of SV40 (simian virus...
Includes: Supplementary data
Articles
Articles
Articles
Biochem J (2011) 436 (3): 631–639.
Published: 27 May 2011
... (Alzheimer's disease). Accumulating evidence reveals that APPc (APP C-terminal domain)-interacting proteins can influence APP processing. There is also evidence to suggest that APPc-interacting proteins work co-operatively and competitively to maintain normal APP functions and processing. Hence, identification...
Includes: Supplementary data
Articles
Biochem J (2011) 434 (3): 503–512.
Published: 24 February 2011
...Claire Thornton; Nicola J. Bright; Magdalena Sastre; Phillip J. Muckett; David Carling Hyperphosphorylation of tau is a hallmark of Alzheimer's disease and other tauopathies. Although the mechanisms underlying hyperphosphorylation are not fully understood, cellular stresses such as impaired energy...
Includes: Supplementary data
Articles
Biochem J (2011) 433 (2): 323–332.
Published: 22 December 2010
...Panchanan Maiti; Roberto Piacentini; Cristian Ripoli; Claudio Grassi; Gal Bitan Aβ (amyloid β-peptide) is believed to cause AD (Alzheimer's disease). Aβ42 (Aβ comprising 42 amino acids) is substantially more neurotoxic than Aβ40 (Aβ comprising 40 amino acids), and this increased toxicity correlates...
Includes: Supplementary data
Articles
Biochem J (2011) 433 (1): 75–83.
Published: 15 December 2010
... interactions and suggests that SNX9 and SNX33 have distinct molecular functions. © The Authors Journal compilation © 2011 Biochemical Society 2011 Alzheimer's disease BAR domain endocytosis molecular modelling protein dimerization sorting nexin 1 To whom correspondence should...
Includes: Supplementary data
Articles
Biochem J (2010) 426 (3): 255–270.
Published: 24 February 2010
...Kirsty E. A. Muirhead; Eva Borger; Laura Aitken; Stuart J. Conway; Frank J. Gunn-Moore The Aβ (amyloid-β peptide) has long been associated with Alzheimer's disease, originally in the form of extracellular plaques. However, in the present paper we review the growing evidence for the role of soluble...
Articles
Biochem J (2009) 421 (3): 415–423.
Published: 15 July 2009
...Emilie Cerf; Rabia Sarroukh; Shiori Tamamizu-Kato; Leonid Breydo; Sylvie Derclaye; Yves F. Dufrêne; Vasanthy Narayanaswami; Erik Goormaghtigh; Jean-Marie Ruysschaert; Vincent Raussens AD (Alzheimer's disease) is linked to Aβ (amyloid β-peptide) misfolding. Studies demonstrate that the level...
Articles
Biochem J (2009) 418 (3): 643–650.
Published: 25 February 2009
...Ascensión Cuesta; Alberto Zambrano; María Royo; Angel Pascual The expression of the APP (amyloid precursor protein), which plays a key role in the development of AD (Alzheimer's disease), is regulated by a variety of cellular mediators in a cell-dependent manner. In this study, we present evidence...
Articles
Biochem J (2009) 417 (1): 213–222.
Published: 12 December 2008
... used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre. Both steps of the HuAChE carbamylation reaction, formation of the Michaelis complex as well as the nucleophilic process...
Articles
Biochem J (2008) 415 (2): 165–182.
Published: 25 September 2008
... players in the death pathways, the current tools for examining these players and the models for studying neurological disease. Alzheimer's disease, the most common neurodegenerative disorder, and cerebral ischaemia, the most common cause of neurological death, are used to illustrate our current...
Articles
Biochem J (2007) 407 (3): 383–395.
Published: 12 October 2007
...Claudio Costantini; Mi Hee Ko; Mary Cabell Jonas; Luigi Puglielli The lipid second messenger ceramide regulates the rate of β cleavage of the Alzheimer's disease APP (amyloid precursor protein) by affecting the molecular stability of the β secretase BACE1 (β-site APP cleaving enzyme 1...
Includes: Supplementary data
Articles
Articles
Biochem J (2007) 404 (2): 309–316.
Published: 14 May 2007
...Véronique Dorval; Matthew J. Mazzella; Paul M. Mathews; Ronald T. Hay; Paul E. Fraser The sequential processing of the APP (amyloid precursor protein) by the β- and γ-secretase and generation of the Aβ (amyloid-β) peptide is a primary pathological factor in AD (Alzheimer's disease). Regulation...
Includes: Supplementary data
Articles